Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06052852
Title Study of BDC-3042 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bolt Biotherapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Center RECRUITING Palo Alto California 94304 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
NEXT Oncology RECRUITING Austin Texas 78758 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field